Myorelax is a 100 mg/ml guaifenesin solution, indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia. It is a centrally acting muscle relaxant which gives minimal cardiovascular depression. Myorelax has little to no effect on the diaphragm and the intercostal muscles, meaning there is little to no disturbance of respiration. Myorelax has no analgetic effect and does not affect consciousness.
|Withdrawal period||Niet voor paarden voor humane consumptie|
|Ingredients||Guaifenesin, dextrose monohydrate, N-Methyl-2-pyrrolidone, water for injection, sodium hydroxide, hydrochloric acid.|
|Batch expiry date||Nov 30, 2022|
|Units per outer box||0|